Mr. Geordan Pursglove, 37, is a distinguished leader and seasoned executive with an impressive track record in corporate governance, business development, and capital markets. As the Chief Executive Officer and Chairman of the Board of Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage biopharmaceutical company, he has spearheaded the company’s mission to advance novel PP2A inhibitors for cancer treatment. Under his leadership, Lixte has successfully raised over $5 million in capital, navigated Nasdaq compliance challenges, and driven the company’s operational growth and visibility in the oncology and immunotherapy sectors.
In addition to his leadership at Lixte, Mr. Pursglove serves as a Member of the Board of Directors for Nasdaq- listed Entero Therapeutics (ENTO) company, further solidifying his influence in the capital markets and his commitment to the growth of innovative companies.
Beyond his role at Lixte, Mr. Pursglove is the Managing Director of 2GP Group LLC, a multi-disciplinary investment firm that he founded and manages. With ventures spanning sports, marketing, sales, and logistics, he has demonstrated exceptional expertise in fostering innovation and growth across a variety of industries.
Mr. Pursglove’s career is marked by more than a decade of experience in mergers and acquisitions, capital markets, and corporate leadership. He previously served on the board of SemiCab Holdings, a leading logistics technology company under Algorhythm Holdings, Inc. (NASDAQ: RIME). There, he was instrumental in the merger between SemiCab and Algorhythm, raised over $10 million in capital, and played a critical role in expanding SemiCab’s global footprint.
Before his involvement with SemiCab, Mr. Pursglove served as President of Service 800, Inc., a premier provider of customer satisfaction and market research solutions for Fortune 500 companies. During his tenure, he led strategic initiatives that significantly enhanced operational performance and revenue growth, solidifying Service 800’s reputation as a leader in its field.
With an unwavering commitment to innovation and growth, Mr. Pursglove continues to leverage his extensive expertise to drive impactful change in the life sciences, technology, and business sectors.
